La chaîne d'options affiche les données clés des options sur actions de Galecto à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Galecto..

Galecto (NASDAQ:GLTO) Stock, Chaîne d'Options

Galecto

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Galecto Inc

News

Management

Press Releases

Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler

Earnings

Galecto Reports Third Quarter 2024 Financial Results

Galecto to Participate in Upcoming Investor Conferences

Galecto Reports Full-Year 2024 Financial Results

Galecto Reports First Quarter 2025 Operating and Financial Results

Galecto Reports Second Quarter 2025 Operating and Financial Results

GLTO

Abpro Hldgs

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals

BriaCell Therapeutics Corp. - Common Shares

BriaCell Therapeutics

Bio Green Med Solution, Inc. - Common Stock

Bio Green Med Solution

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Curis

Edesa Biotech

FibroBiologics

Geovax Labs

iBio

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Longeveron

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Lisata Therapeutics

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

NextCure

BiomX

Propanc Biopharma

Rallybio

SAB Biotherapeutics

Synlogic

Tharimmune

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

Comments

Galecto

Galecto (GLTO) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL